Stability Study of Baclofen in an Oral Powder Form Compounded for Pediatric Patients in Japan

• Autori principali: Jumpei Saito (Autore), Takehisa Hanawa (Autore), Ayuna Ozawa (Autore), Takahiro Matsumoto (Autore), Nozomi Yoshikawa (Autore), Tsutomu Harada (Autore), Kana Iwahashi (Autore), Akimasa Yamatani (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2022-08-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Baclofen is used as a skeletal muscle relaxant for multiple sclerosis patients and pediatric patients with cerebral palsy and is prescribed to pediatric patients at 0.3 to 1.0 mg/kg/dose. Baclofen tablets, an oral drug, are usually administered as a powder in pediatric wards after a formulation chan...